Slowly progressing type 1 diabetes: Persistence of islet cell autoantibodies is related to glibenclamide treatment

Autoimmunity

Volumn 35, Issue 7, 2002, Pages 469-474

  Cabrera Rode, Eduardo ^a   Perich, Pedro ^a   Diaz Horta, Oscar ^a   Tiberti, Claudio ^b   Molina, Gisela ^a   Arranz, Celeste ^a   Martin, Juana M ^a   Licea, Manuel ^a   De Leiva, Alberto ^c   Puig Domingo, Manuel ^c   Dimario, Umberto ^b  

^a INSTITUTO NACIONAL DE ENDOCRINOLOGÍA   (Cuba)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Glibenclamide therapy; Glutamic acid decarboxylase antibodies; Islet cell antibodies; Latent autoimmune diabetes of adult (LADA); Slowly progressing type 1 diabetes; Type 2 diabetes

Indexed keywords

4 AMINOBUTYRIC ACID; AUTOANTIBODY; AUTOANTIGEN; B LYMPHOCYTE ANTIGEN; C PEPTIDE; GLIBENCLAMIDE; GLUCOSE; GLUTAMATE DECARBOXYLASE ANTIBODY; INSULIN; PANCREAS ISLET CELL ANTIBODY; SULFONYLUREA;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DISEASE CONTROL; DISEASE COURSE; DISEASE DURATION; DOSE RESPONSE; DRUG CHOICE; DRUG EFFECT; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HUMORAL IMMUNITY; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN TREATMENT; MALE; METABOLIC REGULATION; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; TREATMENT PLANNING;

AUTOANTIBODIES; BLOOD GLUCOSE; BODY MASS INDEX; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GLUTAMATE DECARBOXYLASE; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; ISLETS OF LANGERHANS; ISOENZYMES;

EID: 12244279058     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.1080/0891693021000050574     Document Type: Article

References (33)

1. Del Prete, G.F., Betterle, C. and Padovan, D. (1977) "Incidence and significance of islet cell antibodies in different types of diabetes mellitus", Diabetes 26, 909-915.
2. Di Mario, U., Irvine, W.J., Borsey, D.Q., Kyner, J.L., Weston, J. and Galfo, C. (1983) "Immune abnormalities in diabetic patients not requiring insulin at diagnosis", Diabetologia 25, 392-395.
3. Groop, L.C., Groop, P.H. and Koskimies, S. (1986) "Relationship between β-cell function and HLA antigens in patients with type 2 (non-insulin dependent) diabetes", Diabetologia 29, 757-760.
4. Groop, L.C., Miettinen, A., Groop, P.H., Meri, S., Koskimies, S. and Bottazzo, G.F. (1988) "Organ-specific autoimmunity and HLA-DR antigens as markers for β-cell destruction in patients with type II diabetes", Diabetes 37, 99-103.
5. Lipton, R. and LaPorte, R. (1989) "Epidemiology of islet cell antibodies", Epidemiologic Rev. 11, 182-203.
6. Gottsater, A., Landin-Olson, M., Fernlund, P., Lernmark, A. and Sundkvist, G. (1993) "β-Cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients", Diabetes Care 16, 902-910.
7. Groop, L., Bottazzo, G.F. and Doniach, D. (1986) "Islet cell antibodies identify latent type I diabetes in patients aged 35-75 years at diagnosis", Diabetes 35, 237-241.
8. Cabrera-Rode, E., Licea, M., Molina, G., Díaz-Horta, O., Arranz, C. and Uriarte, A. (1995) "Immunogenetic, clinical and metabolic characterization of non-insulin dependent diabetes mellitus (NIDDM) according to the presence of islet cell antibodies", Avances en Diabetologia 10, 101-110.
9. Kobayashi, T., Itoh, T., Kosaka, K., Sato, K. and Tsuji, K. (1987) "Time course of islet cell antibodies and β-cell function in non-insulin-dependent stage of type 1 diabetes", Diabetes 36, 510-517.
10. Kobayashi, T., Tamemoto, K., Nakanishi, K., Kato, N., Okubo, M., Kajio, H., et al. (1993) "Immunogenetic and clinical characterization of slowly progressive IDDM", Diabetes Care 16, 780-788.
11. Cabrera-Rode, E., Díaz-Horta, O., Rendón, A., Molina, G., Vera, M., Licea, M., et al. (1997) "Prevalence of Islet Cell Antibodies (ICA) in diabetes mellitus and other diseases in Cubans", Autoimmunity 26, 7-10.
12. Keller, R.J., Eisenbarth, G.S. and Jackson, R.A. (1993) "Insulin prophylaxis in individuals at high risk of type 1 diabetes", Lancet 341, 927-928.
13. Appel, M.C., Dotta, F., O'Neill, J. and Eisenbarth, G.S. (1989) "Beta cell activity regulates the expression of islet antigenic determinants", Diabetologia 32, 461A.
14. Malone, J.I. (1991) In: Rifkin, H., Colwell, J.A. and Taylor, S.I., eds, The Role of Exogenous Insulin in the Pathogenesis of Autoimmune Diabetes Mellitus (Elsevier Science Publisher B.V. Diabetes 1991), 1022-1025.
15. Shah, S.C., Malone, J.I. and Simpson, N.E. (1989) "A randomized trial of intensive insulin therapy in newly diagnosed insulin dependent diabetes mellitus", N. Engl. J. Med. 320, 350-354.
16. Shah, S.C. and Malone, J.I. (1991) "High dose insulin therapy (HDIT) resulted in long term survival of beta cell and disappearance of islet cell antibodies (ICA) in IDDM", Diabetes 40(Suppl. 1), 152A.
17. Bjork, E., Kampe, O., Andersson, A. and Karlsson, F.A. (1992) "Expression of the 64 kDa/glutamic acid decarboxylase rat islet cell autoantigen is influenced by the rate of insulin secretion", Diabetologia 32, 490-493.
18. Kagimoto, S., Yamada, Y., Kubota, A., Ishida, H. and Seino, Y. (1996) "Apoptotic cell death of beta cells triggered by glibenclamide", Diabetologia 39 (Suppl. 1), 404A.
19. Cabrera-Rode, E., Díaz-Horta, O., Rendón, A., Molina, G., Suárex, L.R., Perich, P., et al. (1998) "Prevalence and characteristics of latent autoimmune diabetes in a Cuban type 2 diabetes cohort", Diabetologia 41(Suppl. 1), A170.
20. Trinder, P. (1969) "Determination of glucose oxidase with one alternative oxygen acceptor", Ann. Clin. Biochem. 6, 24-27.
21. Pilcher, C. and Elliott, R.B. (1984) "Improved sensitivity of islet cell cytoplasmic antibody assay in diabetics", Lancet 1, 1352.
22. Mauricio, D., Corcoy, R., Codina, M., Morales, J., Balsells, M. and De Leiva, A. (1995) "Islet cell antibodies and beta-cell function in gestacional diabetes women: Comparison to first-degree relatives of type 1 (insulin-dependent) diabetic subjects", Diabet. Med. 12, 1009-1014.
23. Grubin, C.E., Daniels, T., Toivola, B., Landin-Olsson, M., Hagobian, W.A., Li, L., et al. (1994) "A novel radioligand binding assay to determine diagnostic accuracy of iso-form specific glutamic acid decarboxylase in a childhood population", Diabetologia 37, 344-350.
24. Trischitta, V., Italia, S., Raimondo, M., Guardabasso, V., Licciardello, C., Runello, F., et al. (1998) "Efficacy of combined treatments in NIDDM patients with secondary failure to sulphonylureas. Is it predictable?", J. Endocrinol. Investig. 21(11), 744-747.
25. Atkinson, M.A., MacLaren, N.K. and Luchetta, R. (1990) "Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy", Diabetes 39, 933-937.
26. Arthur, A.L. and Worcester, M.A. (1986) "Insulin injections prevent diabetes (DB) in Biobreeding/Worcester (BB/Wor) rats", Diabetes 35, 74A, (Abstract).
27. Sai, P., Damge, Ch., Riverau, A.S., Hoeltzei, A. and Gouin, E. (1996) "Prophylactic oral administration of metabolically active insulin entrapped in isobutylcyanocrylate nanocapsules reduces the incidence of diabetes in non obese diabetic mice", J. Autoimmun. 9, 713-721.
28. Seissler, J., De Sonnaville, J.J.J., Morgenthaler, N.G., Steinbrenner, H., Glawe, D., Khoo-Morgenthaler, U.Y., et al. (1998) "Immunological heterogeneity in type 1 diabetes: Presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease", Diabetologia 41, 891-897.
29. Tuomi, T., Carlsson, A., Li, H., Isomaa, B., Miettinen, A., Nilsson, A., et al. (1999) "Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies", Diabetes, 150-157.
30. Cabrera-Rode, E., Molina, G., Díaz-Horta, O., Rendon, A., Perich, P., Suárez, L., et al. (1999) "Characteristics of islet cell antibodies in Latent Autoimmune Diabetes of Adult (LADA), Newly Diagnosed Type 1 Diabetes, First degree of relatives of type 1 diabetes and Gestational Diabetes", Rev. Cubana Endocrinol. 10, 85-97.
31. Kobayashi, T., Nakanishi, K., Murase, T. and Kosaka, K. (1996) "Small doses of subcutaneous insulin as strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM", Diabetes 45, 622-626.
32. Naik, R.G. and Palmer, J.P. (1999) "Preservation of β-cell function in type 1 diabetes", Diabetes Rev. 7, 154-182.
33. Pozzilli, P. and Di Mario, U. (2001) "Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): Definition, characterization, and potential prevention", Diabetes Care 24, 1460-1467.